These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 12118439

  • 1. Cost-benefit analysis of hepatitis a vaccination in Thailand.
    Teppakdee A, Tangwitoon A, Khemasuwan D, Tangdhanakanond K, Suramaethakul N, Sriratanaban J, Poovorawan Y.
    Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):118-27. PubMed ID: 12118439
    [Abstract] [Full Text] [Related]

  • 2. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
    Das A.
    Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934
    [Abstract] [Full Text] [Related]

  • 3. Vaccinating Thai adolescents against hepatitis A: is it cost-effective?
    Soogarun S, Wiwanitkit V.
    Southeast Asian J Trop Med Public Health; 2002 Feb; 33 Suppl 3():145-8. PubMed ID: 12971496
    [Abstract] [Full Text] [Related]

  • 4. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
    Jacobs RJ, Greenberg DP, Koff RS, Saab S, Meyerhoff AS.
    Pediatr Infect Dis J; 2003 Oct; 22(10):904-14. PubMed ID: 14551492
    [Abstract] [Full Text] [Related]

  • 5. The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A.
    Jacobs RJ, Koff RS, Meyerhoff AS.
    Am J Gastroenterol; 2002 Feb; 97(2):427-34. PubMed ID: 11866283
    [Abstract] [Full Text] [Related]

  • 6. Cost-utility of universal hepatitis A vaccination in Canada.
    Bauch CT, Anonychuk AM, Pham BZ, Gilca V, Duval B, Krahn MD.
    Vaccine; 2007 Dec 12; 25(51):8536-48. PubMed ID: 17996339
    [Abstract] [Full Text] [Related]

  • 7. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
    Ahmed M, Munshi SU, Nessa A, Ullah MS, Tabassum S, Islam MN.
    Indian J Med Microbiol; 2009 Dec 12; 27(1):48-50. PubMed ID: 19172060
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness analysis of hepatitis A vaccination strategies for adults.
    O'Connor JB, Imperiale TF, Singer ME.
    Hepatology; 1999 Oct 12; 30(4):1077-81. PubMed ID: 10498662
    [Abstract] [Full Text] [Related]

  • 9. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines.
    Bryan JP, Nelson M.
    Arch Intern Med; 1994 Mar 28; 154(6):663-8. PubMed ID: 8129500
    [Abstract] [Full Text] [Related]

  • 10. Cost-effective analysis of hepatitis A prevention in Ireland.
    Rajan E, Shattock AG, Fielding JF.
    Am J Gastroenterol; 2000 Jan 28; 95(1):223-6. PubMed ID: 10638588
    [Abstract] [Full Text] [Related]

  • 11. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C.
    Myers RP, Gregor JC, Marotta PJ.
    Hepatology; 2000 Apr 28; 31(4):834-9. PubMed ID: 10733536
    [Abstract] [Full Text] [Related]

  • 12. Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands).
    Postma MJ, Bos JM, Beutels P, Schilthuis H, van den Hoek JA.
    Vaccine; 2004 May 07; 22(15-16):1862-7. PubMed ID: 15121296
    [Abstract] [Full Text] [Related]

  • 13. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
    Vimolket T, Poovorawan Y.
    Southeast Asian J Trop Med Public Health; 2005 May 07; 36(3):693-9. PubMed ID: 16124440
    [Abstract] [Full Text] [Related]

  • 14. [Seroprevalence of hepatitis A and cost evaluation of different vaccination strategies against hepatitis A virus in patients with chronic hepatitis C in France].
    Rufat P, Dumouchel P, Cadranel JF.
    Gastroenterol Clin Biol; 2002 Mar 07; 26(3):256-60. PubMed ID: 11981470
    [Abstract] [Full Text] [Related]

  • 15. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
    Tilson L, Thornton L, O'Flanagan D, Johnson H, Barry M.
    Eur J Public Health; 2008 Jun 07; 18(3):275-82. PubMed ID: 18160389
    [Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context.
    Sartori AM, de Soárez PC, Novaes HM, Amaku M, de Azevedo RS, Moreira RC, Pereira LM, Ximenes RA, Martelli CM.
    Vaccine; 2012 Dec 14; 30(52):7489-97. PubMed ID: 23107593
    [Abstract] [Full Text] [Related]

  • 17. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States.
    Arguedas MR, Heudebert GR, Fallon MB, Stinnett AA.
    Am J Gastroenterol; 2002 Mar 14; 97(3):721-8. PubMed ID: 11922569
    [Abstract] [Full Text] [Related]

  • 18. Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States.
    Rein DB, Hicks KA, Wirth KE, Billah K, Finelli L, Fiore AE, Hoerger TJ, Bell BP, Armstrong GL.
    Pediatrics; 2007 Jan 14; 119(1):e12-21. PubMed ID: 17200237
    [Abstract] [Full Text] [Related]

  • 19. A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China.
    Zhuang GH, Pan XJ, Wang XL.
    Vaccine; 2008 Aug 18; 26(35):4608-16. PubMed ID: 18597903
    [Abstract] [Full Text] [Related]

  • 20. [Cost-benefit analysis for hepatitis A vaccine].
    Chen E, Yao J, Yang J.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Aug 18; 20(4):224-7. PubMed ID: 10682501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.